Oral Abstract Presentations
| Abstract Title | Presenter | Category | |
|---|---|---|---|
| Antigenic characterization of human noroviruses reveals limited cross-blocking between genotypes | Lauren Ford-Siltz, Food and Drug Administration | Vaccines and immunity | |
| Burden of viral pathogens causing acute gastroenteritis in children less than 2 years of age in a U.S. birth cohort | Jennifer Cannon, CDC Foundation | Epidemology | |
| Capture-based metaviromics to describe caliviridae diversity in contaminated shellfish | Soizick F. Le Guyader, IFREMER Institute | Food & Environmental Virology-I (Food) | |
| Challenges in the culture of norovirus isolated from oyster tissues | Marion Desdouits, Ifremer | Food & Environmental Virology-I (Food) | |
| Characterization of Binding and Antigenic Properties in Emerging GII.17 Norovirus Variants | Francisco Morais Esteves, Erasmus MC | Molecular Epidemiology & Evolution | |
| Characterization of human norovirus and host genetic susceptibility profiling in South African children with gastroenteritis | Ronewa Khumela, University of Pretoria | Molecular Epidemiology & Evolution | |
| CRISPR-Cas13a Coupled with a Capsid Integrity Assay for Detecting Norovirus in Food | Axel Ossio, Universidad Autonoma de Nuevo Leon | Advances in diagnostics and detection | |
| Development of an ex vivo model to study the zoonotic transmission of noroviruses | Nele Villabruna, University of Veterinary Medicine Hanover | Entry and Replication | |
| Development of Reporter Replicon Systems for Genogroup II Human Noroviruses: Tools for Antiviral Screening and Mechanistic Insight | Myra Hosmillo, University of Cambridge | Prevention & Control (antivirals) | |
| Direct comparison of the persistence of infectious human norovirus and its cultivable surrogate, hepatitis A virus, on frozen raspberries | Émilie Larocque, Canadian Food Inspection Agency | Food & Environmental Virology-I (Food) | |
| Dynamics of asymptomatic Norovirus infections in a three-year cohort of children from rural communities in Ecuador. | Rommel Guevara, Universidad San Francisco de Quito | Molecular Epidemiology & Evolution | |
| Dysregulated innate epithelial response to norovirus infection in intestinal organoids from patients with common variable immunodeficiency | Magdalena Neijd, Linköping University, Sweden | Entry and Replication | |
| Efficacy, safety, immunogenicity, and cross-reactivity of intramuscular HIL-214 norovirus vaccine in healthy children 5 Months of age at initial vaccination | Robert Hershberg, HilleVax | Vaccines and immunity | |
| Emergence of GII.3 as most prevalent norovirus strain among infants and children with acute gastroenteritis in Bangladesh | Shuvra Kanti Dey, Jahangirnagar University | Molecular Epidemiology & Evolution | |
| Evaluation of MMV Pandemic Response Box compounds identifies MMP-inhibitor against HuNoV replication | Myra Hosmillo, University of Cambridge | Prevention & Control (antivirals) | |
| Evaluation of sensitivity and specificity of New Immunochromatograpghy (IC) kit for the rapid detection of norovirus associated acute gastroenteritis in Dhaka, Bangladesh | Shuvra Kanti Dey, Jahangirnagar University | Advances in diagnostics and detection | |
| Gastrointestinal viral Infection in Adult and Pediatric Solid Organ Transplant Recipient: A Retrospective, Single-center Study from 2015 to 2022 | Varalika Tyagi, University of Alberta | Epidemology | |
| Genotypic distribution and molecular epidemiology of norovirus among under-five children hospitalized with acute gastroenteritis in South India, 2005-2020 | Tintu Varghese, Christian Medical College Vellore | Molecular Epidemiology & Evolution | |
| Global trends in norovirus genotype distribution among children with acute gastroenteritis captured by NoroSurv, 2020-2025 | Jennifer Cannon, CDC Foundation | Molecular Epidemiology & Evolution | |
| Human milk oligosaccharides and norovirus GII gastroenteritis in a Nicaraguan birth cohort | Rebecca Rubinstein, University of North Carolina at Chapel Hill | Epidemology | |
| Human Norovirus Replicates in Hepatocytes and Other Liver Cells in Zebrafish Larvae | Lorane Molineaux, KU Leuven | Entry and Replication | |
| Identification of a Cellular Host Factor Required for Human Sapovirus Infection | Kei Haga, Kitasato University | Entry and Replication | |
| Increased norovirus activity associated with the emergence of GII.17[P17] in season 2023/24 in Germany | Sandra Niendorf, Robert Koch Institute | Molecular Epidemiology & Evolution | |
| Intercellular calcium waves are a conserved feature of enteric virus infection and drive Tulane virus spread | Joseph Hyser, Baylor College of Medicine | Entry and Replication | |
| Milk IgAs of early life origin B cells have cross-neutralizing antiviral properties | Hannah Karen Labayo, NIH-NHLBI | Vaccines and immunity | |
| Molecular Characterization and Isolation of Contemporary Porcine Sapoviruses from Swine Farms in the United States | Qiuhong Wang, The Ohio State University | Molecular Epidemiology & Evolution | |
| Molecular Characterization of Human Noroviruses among Children with Acute Gastroenteritis in Ebonyi State, Nigeria | Olumuyiwa Babalola Salu, College of Medicine, University of Lagos | Epidemology | |
| Mutational Analysis of Human Norovirus VP2 Elucidates Critical Molecular Interactions for Virus Assembly | Sue Crawford, Baylor College of Medicine | Structure & Pathogenesis | |
| Neutralizing antibody responses to GII.4 vaccination from early childhood through old age: harnessing the power of immune imprinting to drive breadth. | Lisa Lindesmith, University of North Carolina-Chapel Hill | Vaccines and immunity | |
| Next Generation Oral Norovirus Vaccine Candidate Generates Improved Immune Responses to GI.I and GII.4 strains in Humans | Sean N. Tucker, Vaxart, Inc | Vaccines and immunity | |
| Norovirus alters host metabolism for efficient virus replication | Adam Hafner, University of Michigan | Entry and Replication | |
| Norovirus and Sapovirus Associated Chronic Diarrhea in SOT: Does Viral Load Correlate with Severity of Symptoms? | Varalika Tyagi, University of Alberta | Epidemology | |
| Norovirus Shedding in Symptomatic and Asymptomatic Patients: Insights from a Tertiary Care Hospital-Based Study in Bangladesh | Syed Moinuddin Satter, icddr,b | Epidemology | |
| Oral Direct-Acting Antiviral CDI-988 for norovirus infection prevention and treatment: Mechanism of Action and Phase 1 Study Results | Sam Lee, Cocrystal Pharma Inc. | Prevention & Control (antivirals) | |
| Overcoming host restriction to enable continuous passaging of human noroviruses in human intestinal enteroids | Gurpreet Kaur, Baylor college of medicine | Entry and Replication | |
| Polyamine depletion inhibits norovirus infection and blocks virus-induced apoptosis | Stefan Taube, University of Lübeck | Prevention & Control (antivirals) | |
| Repertoire of naturally acquired norovirus maternal antibodies in newborns | Verónica Costantini, Centers for Disease Control and Prevention | Vaccines and Immunity | |
| Safety and Immunogenicity of mRNA-1403, a Multivalent Norovirus mRNA Vaccine, in Healthy Adults: Interim Results of a Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial | Meklit Workneh, Moderna | Vaccines and immunity | |
| Screening Norovirus Genetic Diversity in Public Datasets using Aitne, a Novel Open Source Genotyper | Dennis Schmitz, Erasmus Medical Center / Netherlands Institute of Public Health and the Environment (RIVM) | Molecular Epidemiology & Evolution | |
| Single-cell transcriptomic analysis of duodenal biopsies and enteroids from immunocompromised patients with chronic norovirus infection | Yuki Matsushima, Caliciviruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health | Entry and Replication | |
| Sporadic, Medically Attended Norovirus Infection in the United States, 2023-2024 | Mark Schmidt, Kaiser Permanente Center for Health Research | Epidemology | |
| Structural studies of the calcivirus entry pathway – conformational flexibility as a marker of virulence? | David Bhella, MRC - University of Glasgow Centre for Virus Research | Structure & Pathogenesis | |
| Structure of the Norovirus NTPase | Daniel Hurdiss, Utrecht University | Structure & Pathogenesis | |
| Targeting calicivirus entry – a VP2 peptide inhibitor of Feline Calicivirus | Charlotte Lewis, University of Glasgow Centre for Virus Research | Prevention & Control (antivirals) | |
| Targeting the Gut: Oral Norovirus Vaccine Generates Protective Mucosal Immunity and Reduces Viral Shedding Following GI.1 Challenge | Becca Flitter, Vaxart | Vaccines and immunity | |
| The final straw: berries and viruses. | Malak Esseili, University of Georgia | Food & Environmental Virology-I (Food) | |
| Wastewater-based epidemiology at a global scale for norovirus surveillance: From metagenomics to phenotypical characterization | Ray William Izquierdo Lara, Erasmus MC | Food & Environmental Virology-II (Wastewater & others) | |
| Wastewater-based Surveillance of Norovirus and Sapovirus from 2020 - 2024 in Alberta, Canada | Judy Qiu, Alberta Public Health Laboratory/University of Alberta | Food & Environmental Virology-II (Wastewater & others) |